|
FY2017
12 months to Dec 31, 2017
|
FY2016
12 months to Dec 31, 2016
|
FY2015
12 months to Dec 31, 2015
|
FY2014
12 months to Dec 31, 2014
|
FY2013
12 months to Dec 31, 2013
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net (loss) income | |||||
| Adjustments to reconcile net income to net cash (used in) provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Amortization of deferred gain | |||||
| Net amortization of bond premium or discount | |||||
| Equity earnings on investment in unconsolidated subsidiaries | |||||
| Gain on investment in life settlement contracts, net | |||||
| Realized gain on marketable securities | |||||
| Non-cash write-down of marketable securities | |||||
| Non-cash write-down of investments | |||||
| Non-cash write-down of goodwill | |||||
| Discount on notes payable | |||||
| Stock based compensation | |||||
| Loss on extinguishment of debt | |||||
| Bad debt expense | |||||
| Foreign currency loss (gain) | |||||
| Gain on sale of policy management system | |||||
| Acquisition gain | |||||
| Dividend received from equity investment | |||||
| Changes in assets – (increase) decrease: | |||||
| Premiums and notes receivable | |||||
| Reinsurance recoverable | |||||
| Deferred policy acquisition costs, net | |||||
| Prepaid reinsurance premiums | |||||
| Prepaid expenses and other assets | |||||
| Changes in liabilities – increase (decrease): | |||||
| Reinsurance premium payable | |||||
| Loss and loss expense reserves | |||||
| Unearned premiums | |||||
| Funds held under reinsurance treaties | |||||
| Accrued expenses and other current liabilities | |||||
| Deferred tax asset and liability, net | |||||
| Net cash (used in) provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Purchases of: | |||||
| Fixed maturity securities, available-for-sale | |||||
| Equity securities, available-for-sale | |||||
| Equity securities, trading | |||||
| Other investments | |||||
| Subsidiaries, net of cash received | |||||
| Acquisition of intangible assets | |||||
| Sale of subsidiary | |||||
| Property, equipment and software | |||||
| Life settlement contracts | |||||
| Sales of: | |||||
| Fixed maturity securities, available-for-sale (includes maturities & paydowns) | |||||
| Equity securities, available-for-sale | |||||
| Equity securities, trading | |||||
| Other investments | |||||
| Securities sold but not purchased, net | |||||
| Equity method investment | |||||
| Life settlement contracts | |||||
| Policy management system | |||||
| Short term investments (purchases) sales, net | |||||
| Advance on equity interest in life settlement contracts entity | |||||
| Receipt of life settlement contract proceeds | |||||
| Loan to ACP Re | |||||
| Acquisition of reinsurance entities, net of cash obtained | |||||
| Decrease (Increase) in restricted cash and cash equivalents, net | |||||
| Net cash provided by (used in) investing activities | |||||
| Cash flows from financing activities: | |||||
| Revolving credit facility borrowings | |||||
| Revolving credit facility payments | |||||
| Repurchase agreements, net | |||||
| Secured loan agreement borrowings | |||||
| Secured loan agreement payments | |||||
| Promissory note payments | |||||
| 2055 Subordinated notes proceeds | |||||
| Senior notes proceeds | |||||
| Convertible senior notes proceeds | |||||
| Convertible senior notes payments | |||||
| Financing fees | |||||
| Common share (repurchase) issuance | |||||
| Common share issuance | |||||
| Common share repurchase | |||||
| Preferred share issuance | |||||
| Contingent consideration payments | |||||
| Non-controlling interest capital (dividends) contributions to consolidated subsidiaries, net | |||||
| Stock option exercise and other | |||||
| Dividends distributed on common stock | |||||
| Dividends distributed on preferred stock | |||||
| Net cash (used in) provided by financing activities | |||||
| Effect of exchange rate changes on cash | |||||
| Cash included in business classified as held for sale | |||||
| Net increase (decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents, beginning year | |||||
| Cash and cash equivalents, end of year | |||||
| Supplemental Cash Flow Information | |||||
| Interest payments on debt | |||||
| Income tax payments | |||||
| Declared dividends on common stock | |||||
Loading...